Nicotinamide Riboside, Vitamin B3 Form Ta... - Cure Parkinson's

Cure Parkinson's

25,550 members26,870 posts

Nicotinamide Riboside, Vitamin B3 Form Taken in Trial, Aids Cell Energy

Farooqji profile image
3 Replies

A modified form of vitamin B3 called nicotinamide riboside (NR), taken as an oral supplement, increased levels of an energy production molecule in the brain and altered brain metabolism over one month in a small group of newly diagnosed Parkinson’s disease patients, according to results of a Phase 1 trial.

parkinsonsnewstoday.com/202...

Written by
Farooqji profile image
Farooqji
To view profiles and participate in discussions please or .
Read more about...
3 Replies

healthunlocked.com/cure-par...

Bolt_Upright profile image
Bolt_Upright

The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson's disease

pubmed.ncbi.nlm.nih.gov/352...

So a 30 day study using 1,000 mg of nicotinamide riboside a day. Interesting.

"We conducted a double-blinded phase I clinical trial to establish whether nicotinamide adenine dinucleotide (NAD) replenishment therapy, via oral intake of nicotinamide riboside (NR), is safe, augments cerebral NAD levels, and impacts cerebral metabolism in Parkinson's disease (PD). Thirty newly diagnosed, treatment-naive patients received 1,000 mg NR or placebo for 30 days. NR treatment was well tolerated and led to a significant, but variable, increase in cerebral NAD levels-measured by 31phosphorous magnetic resonance spectroscopy-and related metabolites in the cerebrospinal fluid. NR recipients showing increased brain NAD levels exhibited altered cerebral metabolism, measured by 18fluoro-deoxyglucose positron emission tomography, and this was associated with mild clinical improvement. NR augmented the NAD metabolome and induced transcriptional upregulation of processes related to mitochondrial, lysosomal, and proteasomal function in blood cells and/or skeletal muscle. Furthermore, NR decreased the levels of inflammatory cytokines in serum and cerebrospinal fluid. Our findings nominate NR as a potential neuroprotective therapy for PD, warranting further investigation in larger trials. "

Bolt_Upright profile image
Bolt_Upright in reply to Bolt_Upright

This had me doubting my Niacin treatment, so I e-mailed one of the doctors involved in the NR trial and asked if Nicotinamide Riboside was better than Nicotinic Acid to boost NAD and lower inflammation, and they told me the two should work about the same to boost NAD and that there is still no conclusive evidence regarding lowering inflammation.

So... I stick with the cheaper straight Niacin.

My only question is... I take 250 mg based on the Auburn trial. The NR trial used 1000 mg to boost NAD. This other trial using Niacin to boost NAD used 750 to 1000 mg: sciencedirect.com/science/a...

I guess I will still stick with my 250 mg time released Niacin.

You may also like...

SoPD blog post from Simon on the recent results from the NADPARK trial of nicotinamide riboside (Niagen)

rom-the-phase-i-trial-the-nadpark-study-a-randomized-phase-i-trial-of-nicotinamide-riboside-suppleme

Encouraging results from the phase-I trial! The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in PD

Highlights • Oral NR increases brain NAD levels in individuals with Parkinson’s disease • NR...

Hot off the press. Randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson’s disease.

Abstract Nicotinamide adenine dinucleotide (NAD) replenishment therapy using nicotinamide riboside...

Vitamin B3 trial results

study of 2 low doses (100 & 250mg) of Niacin (vitamin B3 derivative) in 47 people with #Parkinsons;...

Nicotinamide Riboside (TruNiagen brand)

familiar with Nicotinamide Riboside (Tru Niagen brand) as a means of combating Parkinson’s Disease....